Purity Independent Subtyping of Tumors (PurIST), a clinically robust, single sample classifier for tumor subtyping in pancreatic cancer

PURPOSE: Molecular subtyping for pancreatic cancer has made substantial progress in recent years, facilitating the optimization of existing therapeutic approaches to improve clinical outcomes in pancreatic cancer. With advances in treatment combinations and choices, it is becoming increasingly impor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Rashid, Naim U, Peng, Xianlu L., Jin, Chong, Moffitt, Richard A., Volmar, Keith E., Belt, Brian A., Panni, Roheena Z., Nywening, Timothy M., Herrera, Silvia G., Moore, Kristin J., Hennessey, Sarah, Morrison, Ashley B., Kawalerski, Ryan, Nayyar, Apoorve, Chang, Audrey E., Schmidt, Benjamin, Kim, Hong Jin, Linehan, David C., Yeh, Jen Jen
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942634/
https://ncbi.nlm.nih.gov/pubmed/31754050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados